4-Chloro-2-(methylthio)quinazoline

Marketed by Shanghai Rlavie Technology Co.,ltd, 4-Chloro-2-(methylthio)quinazoline (CAS 58803-74-0) is a pharmaceutical-grade specialty intermediate, produced to Chinese Pharmacopoeia (ChP), US Pharmacopoeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), Japanese Pharmacopoeia (JP), International Pharmacopoeia, and Indian Pharmacopoeia (IP) standards. The company produces it in-house, shipping to North and South America, Europe, Asia, Australasia, the Middle East, and Africa.